SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 65 filers reported holding SYNERON MEDICAL LTD in Q2 2016. The put-call ratio across all filers is 153.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,424,000 | +33.3% | 130,049 | +28.4% | 0.14% | +32.1% |
Q1 2017 | $1,068,000 | +25.6% | 101,249 | 0.0% | 0.11% | +24.7% |
Q4 2016 | $850,000 | +17.2% | 101,249 | 0.0% | 0.08% | +32.8% |
Q3 2016 | $725,000 | -6.9% | 101,249 | 0.0% | 0.06% | -8.6% |
Q2 2016 | $779,000 | +5.3% | 101,249 | 0.0% | 0.07% | +2.9% |
Q1 2016 | $740,000 | -5.2% | 101,249 | 0.0% | 0.07% | -2.9% |
Q4 2015 | $781,000 | +7.9% | 101,249 | 0.0% | 0.07% | +27.3% |
Q3 2015 | $724,000 | -32.7% | 101,249 | 0.0% | 0.06% | -25.7% |
Q2 2015 | $1,075,000 | -14.2% | 101,249 | 0.0% | 0.07% | -14.0% |
Q1 2015 | $1,253,000 | +32.6% | 101,249 | 0.0% | 0.09% | +38.7% |
Q4 2014 | $945,000 | -6.9% | 101,249 | 0.0% | 0.06% | -15.1% |
Q3 2014 | $1,015,000 | -2.9% | 101,249 | 0.0% | 0.07% | +5.8% |
Q2 2014 | $1,045,000 | -11.7% | 101,249 | +6.6% | 0.07% | -13.8% |
Q1 2014 | $1,183,000 | +1.2% | 95,000 | 0.0% | 0.08% | -2.4% |
Q4 2013 | $1,169,000 | +42.7% | 95,000 | 0.0% | 0.08% | +30.2% |
Q3 2013 | $819,000 | -1.0% | 95,000 | 0.0% | 0.06% | -12.5% |
Q2 2013 | $827,000 | – | 95,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DRILL CRAIG A | 1,700,000 | $12,172,000 | 49.92% |
NORTH TIDE CAPITAL, LLC | 3,500,000 | $25,060,000 | 2.73% |
Senvest Management, LLC | 3,843,251 | $27,518,000 | 1.97% |
PERRITT CAPITAL MANAGEMENT INC | 424,570 | $3,040,000 | 0.76% |
Camber Capital Management LP | 2,347,593 | $16,809,000 | 0.74% |
DALTON GREINER HARTMAN MAHER & CO | 1,550,006 | $11,098,000 | 0.72% |
Profit Investment Management, LLC | 88,777 | $636,000 | 0.63% |
DAFNA Capital Management LLC | 85,947 | $615,000 | 0.43% |
Lapides Asset Management, LLC | 326,800 | $2,340,000 | 0.40% |
BRANDES INVESTMENT PARTNERS, LP | 3,414,913 | $24,450,000 | 0.37% |